CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Therapy InterventionWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.07

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth

This study seeks to assess the impact of physical and pulmonary rehabilitation on patients who have been diagnosed with COVID-19 in the short and long term in hopes of establishing a best practices protocol for treatment of future patients with this disease.

NCT04385901 SARS-CoV 2 SARS Pneumonia Behavioral: Therapy Intervention

Primary Outcomes

Description: Validated test demonstrating functional gait capacity and endurance; measuring change in capacity over time in 6 month increments.

Measure: Change in 6 Minute Walk Test

Time: From 6 to 24 months post diagnosis

Description: Validated questionnaire assessing function and quality of life for patients with pulmonary function issues

Measure: Change in Short Form 35 (SF-36) Questionnaire

Time: From 6 to 24 months post diagnosis

Secondary Outcomes

Description: Use of grip dynamometer and isokinematic lower extremity testing to determine muscle capacity

Measure: Change in Strength testing

Time: From 6 to 24 months post diagnosis

Description: Measures lung output capacity

Measure: Change in Peak Flow Meter Test

Time: From 6 to 24 months post diagnosis

Related HPO nodes (Using clinical trials)